Pages that link to "Q72017065"
Jump to navigation
Jump to search
The following pages link to Prevention of Wilson's Disease in Asymptomatic Patients (Q72017065):
Displaying 50 items.
- Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation? (Q31935095) (← links)
- Copper chelation therapy in intrahepatic cholestasis of childhood (Q33482132) (← links)
- Effect of D-penicillamine treatment on brain metabolism in Wilson's disease: a case study (Q33631469) (← links)
- Histological demonstration of copper and copper-associated protein in chronic liver diseases (Q33846528) (← links)
- Caeruloplasmin isoforms in Wilson's disease in neonates (Q33858012) (← links)
- Food intolerance in humans (Q34052255) (← links)
- Liver Copper Content in Patients with Inflammatory Bowel Disease and Associated Liver Disorders (Q34230779) (← links)
- Wilson's disease in Scotland (Q34395173) (← links)
- Copper kinetics in liver disease (Q34473113) (← links)
- Treatment of Wilson's disease with zinc: XV long-term follow-up studies (Q34477827) (← links)
- Diagnosis and treatment of Wilson disease: an update (Q34782089) (← links)
- Copper metalloregulation of gene expression (Q34989940) (← links)
- Eight closely linked loci place the Wilson disease locus within 13q14-q21. (Q35247717) (← links)
- A genetic study of Wilson's disease: evidence for heterogeneity (Q35569385) (← links)
- Wilson's disease: a common liver disorder? (Q35816273) (← links)
- The significance of variations in the distribution of copper in liver disease (Q35863658) (← links)
- Inborn errors of metabolism: principles and their applications (Q35926081) (← links)
- Changes in the distribution of hepatic copper in relation to the progression of Wilson's disease (hepatolenticular degeneration) (Q36051857) (← links)
- Wilson's disease: Current status (Q36211297) (← links)
- Prospective evaluation of the diagnostic accuracy of hepatic copper content, as determined using the entire core of a liver biopsy sample (Q36554476) (← links)
- Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease (Q36615959) (← links)
- Copper: not too little, not too much, but just right. Based on the triennial Pewterers Lecture delivered at the National Hospital for Neurology, London, on 23 March 1995. (Q36669382) (← links)
- Wilson's disease: the problem of delayed diagnosis (Q36966100) (← links)
- Perspectives on Wilson's disease (Q37978782) (← links)
- Non-invasive quantitation of corneal copper in hepatolenticular degeneration (Wilson's disease) (Q39367826) (← links)
- Is copper hepatotoxic in primary biliary cirrhosis? (Q39373939) (← links)
- Post-thyroidectomy hypocalcaemia: A feature of the operation or the thyroid disorder? (Q39428678) (← links)
- Liver disease in infants. Part II: hepatic disease states (Q39432664) (← links)
- Increased hepatic copper concentration in Indian childhood cirrhosis (Q39550009) (← links)
- Cytoplasmic copper and its toxic effects. Studies in Indian childhood cirrhosis (Q39550017) (← links)
- Diagnosis of Treatable Wilson's Disease (Q39724196) (← links)
- Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature (Q39794476) (← links)
- Immune disorders of the gastrointestinal tract and liver (Q39832741) (← links)
- Treatment of inherited disease: realized and potential. (Q39981135) (← links)
- The uses of liver biopsy (Q40351528) (← links)
- The outlook for the diagnosis of Wilson's disease (Q40817953) (← links)
- Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children (Q41506128) (← links)
- Hereditary hypoceruloplasminemia (Q41550389) (← links)
- Wilson's disease: assessment of D-penicillamine treatment (Q41788055) (← links)
- Orthotopic liver transplantation for Wilson's disease (Q41952555) (← links)
- The genetics of Wilson disease (Q42380502) (← links)
- Increased abundance of GABAA receptor subunit mRNAs in the brain of Long-Evans Cinnamon rats, an animal model of Wilson's disease (Q42536997) (← links)
- An assessment of efficiency in potential screening for Wilson's disease (Q42670708) (← links)
- A Highly Efficient and Extremely Selective Intracellular Copper Detoxifying Agent Based on Nanoparticles of ZnMoS4. (Q43201965) (← links)
- Zinc treatment for symptomatic Wilson disease: moving forward by looking back (Q43251930) (← links)
- Copper in Hepatocyte Lysosomes of the Toad, Bufo marinus L (Q43694941) (← links)
- Diagnosis and treatment of presymptomatic Wilson's disease (Q44227697) (← links)
- Penicillamine in Wilson's disease (Q44776826) (← links)
- Clinical diagnosis of the dyskinesias (Q45302503) (← links)
- Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms (Q45341390) (← links)